Chemical structure and classification
Furazolidone is a classic representative of the class of synthetic antimicrobial agents — nitrofuran derivatives. The chemical architecture of all drugs in this group is built on a single principle, which is important to understand for the pharmacology exam.
The base of the molecule is a furan ring. A critically important, mandatory element without which the drug loses its antimicrobial activity is the nitro group ($-NO_2$) attached strictly at the C5 position.
Differences between drugs within the group are due to a variable element — various substituents (radicals) at the C2 position. It is this radical that determines which specific drug is synthesized: furazolidone, nitrofurantoin (furadontin), furazidine (furagin), nitrofural (furacilin), or nifuroxazide (enterofuril).
Pharmacokinetics: why does the drug work in the intestine?
The key pharmacokinetic characteristic of furazolidone is its extremely low bioavailability upon oral administration. The drug is very poorly absorbed in the gastrointestinal tract. In general pharmacology, low absorption is often seen as a disadvantage, but for agents intended to treat intestinal infections, this is the main therapeutic advantage.
Due to the absence of systemic absorption, furazolidone is not distributed throughout the body, but accumulates, creating a stably high concentration of the active substance directly in the intestinal lumen. It acts locally, destroying pathogenic flora. A similar pharmacokinetic profile is exhibited by another nitrofuran — nifuroxazide, which is used for GI infections (enterocolitis and acute diarrhea).
Indications for use: bacteria and protozoa
The spectrum of action of the drug covers both bacterial and protozoal infections. The main targets of therapy:
- Giardiasis. Due to accumulation in the intestinal lumen, the drug effectively affects protozoa parasitizing in the gastrointestinal tract.
- Trichomoniasis. The causative agent of the disease is Trichomonas vaginalis. The main goal of pharmacotherapy in this case is the complete eradication of the pathogen. It is important to remember that the main group for the treatment of trichomoniasis is nitroimidazoles (systemic tablets and vaginal suppositories of metronidazole, ornidazole, tinidazole). Furazolidone, on the other hand, acts as an alternative agent prescribed when the use of the main group is impossible for any reason.
Dosaging regimen and prescription rules
The drug is used exclusively orally (internally). For adult patients, the prescription reference book establishes the following therapeutic ranges:
- Dosage form: 0.05 g tablets.
- Standard single dose: 0.1–0.15 g (which corresponds to taking 2–3 tablets at a time).
- Maximum single dose (MSD): 0.2 g (maximum 4 tablets per single dose).
- Maximum daily dose (MDD): 0.8 g (maximum 16 tablets per day).
Prescription example: Rp.: Tab. Furazolidoni 0.05 D.t.d. N. 20 S. Orally, 2 tablets (0.1 g) 4 times a day.
Briefly: answers to topical questions
What is the mechanism of the antimicrobial action of furazolidone?
The mechanism of the antimicrobial action of furazolidone consists of direct interference with the metabolic processes of the microbial cell. As a representative of the nitrofuran derivative group, the drug exerts a bactericidal effect, which is realized through two main pathways:
- Disruption of respiration — inhibition of cellular respiration of microorganisms occurs.
- Blockade of nucleic acid synthesis — the drug causes inhibition of RNA replication.
Due to these mechanisms, furazolidone exhibits high antimicrobial activity with low toxicity to humans.
For which bacterial infections is furazolidone indicated?
Furazolidone is indicated for the treatment of a number of bacterial infections of the gastrointestinal tract and urinary tract. According to sources, the drug is used in the following cases:
- Shigellosis — prescribed for mild forms of the disease, and also serves as an alternative drug for moderate and severe courses of acute intestinal infections.
- Helicobacteriosis — used in Helicobacter pylori eradication therapy regimens as a synthetic antimicrobial agent.
- Urinary tract infections — used systemically as a urinary antiseptic since it creates high concentrations in the urine.
What side effects are characteristic of furazolidone?
Furazolidone is characterized by the development of specific adverse reactions associated with its enzyme-inhibiting activity. The sources describe the following effects:
- Monoamine oxidase (MAO) inhibition — the drug has hidden MAO activity, which can lead to intolerance to a number of drugs and tyramine-containing foods.
- Disulfiram-like reaction — furazolidone delays alcohol metabolism at the acetaldehyde stage. Consuming alcohol during therapy causes a severe somatovegetative reaction accompanied by dyspnea, vomiting, and fear of death.
With which drugs and substances is furazolidone clinically incompatible?
Furazolidone is clinically incompatible with alcohol, dopamine, and a number of psychotropic drugs.
- Alcohol — co-administration causes a severe somatovegetative reaction (dyspnea, vomiting, fear of death) due to delayed ethanol metabolism.
- Dopamine — furazolidone enhances the intensity and duration of the cardiostimulatory and pressor effects of dopamine.
- MAOI-interacting drugs and foods — since furazolidone has hidden MAO activity, it is potentially incompatible with tricyclic antidepressants, SSRIs, antipsychotics, psychostimulants, epinephrine, reserpine, as well as tyramine-containing foods (cheese, legumes, chocolate).
Against which specific bacteria is furazolidone active?
Furazolidone has a broad spectrum of activity covering both gram-positive and gram-negative bacteria. Among specific bacterial species, educational materials explicitly mention only Helicobacter pylori, against which the drug is used in eradication regimens. Activity against shigellosis pathogens (Shigella) is also indirectly confirmed, as the drug is indicated for the etiotropic treatment of mild, moderate, and severe forms of this intestinal infection.
Nitrofurans with a nitro group at C5 hit the target precisely: Furazolidone is poorly absorbed, so it remains in the intestinal lumen and destroys Giardia.
Class and exam questions
What group does furazolidone belong to and what is its chemical basis?
This is a synthetic antimicrobial agent from the nitrofuran derivative group. Its base is a furan ring with an obligatory nitro group ($-NO_2$) at the C5 position and a variable radical at the C2 position.
Why are furazolidone and nifuroxazide used to treat intestinal infections?
Both drugs share a common pharmacokinetic feature — they are extremely poorly absorbed in the gastrointestinal tract. This allows creating a high concentration of the antimicrobial substance directly in the intestinal lumen.
Is furazolidone a drug of choice for the treatment of trichomoniasis?
No. The main group for the eradication of Trichomonas vaginalis is nitroimidazoles (metronidazole, ornidazole, tinidazole). Nitrofurans (specifically furazolidone) are used only as an alternative group.
What else to study on this topic
- Comparative characteristics of nitrofurans: dependence of the site of action on the radical at the C2 position.
- Mechanism of action of nitroimidazoles (metronidazole, ornidazole) as the main group in trichomoniasis.
- Pharmacokinetics of nitrofurantoin (furadontin) and furazidine (furagin): why they act in the urinary tract rather than the intestine.
- Life cycle of Trichomonas vaginalis and Giardia: justification for choosing systemic or local therapy.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Furazolidone" and 5,304 other pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.